Scopus BioPharma Inc (SCPS)
0.0003
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Scopus BioPharma Cash from Operations (Quarterly): -1.009M for June 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.009M |
| March 31, 2023 | -0.7599M |
| December 31, 2022 | -0.4219M |
| September 30, 2022 | -0.8517M |
| June 30, 2022 | -2.876M |
| March 31, 2022 | -3.978M |
| December 31, 2021 | -4.149M |
| September 30, 2021 | -2.517M |
| June 30, 2021 | -1.962M |
| March 31, 2021 | -2.797M |
| Date | Value |
|---|---|
| December 31, 2020 | -0.9193M |
| September 30, 2020 | -0.6611M |
| June 30, 2020 | -0.8182M |
| March 31, 2020 | -0.1267M |
| December 31, 2019 | -0.6057M |
| September 30, 2019 | -0.6017M |
| June 30, 2019 | -0.6247M |
| March 31, 2019 | -0.2883M |
| June 30, 2018 | -0.1117M |
| March 31, 2018 | -0.2109M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.149M
Minimum
Dec 2021
-0.1267M
Maximum
Mar 2020
-1.566M
Average
-0.8855M
Median
Cash from Operations (Quarterly) Benchmarks
| Bhang Inc | -0.2664M |
| Cantabio Pharmaceuticals Inc | -0.2582M |
| Affymax Inc | -- |
| Predictive Technology Group Inc | -3.366M |
| Statera BioPharma Inc | -0.8015M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.0447M |
| Free Cash Flow | -3.043M |
| Free Cash Flow Per Share (Quarterly) | -0.0254 |